[144] Twist Bioscience Corp SEC Filing

Rhea-AI Filing Summary

Insider filing (Form 144): The filing reports multiple small sales of Common Stock by Robert F. Werner under Rule 144. The disclosed transactions show sales of 7,000 shares on 02/04/2026, 1,693 shares on 02/23/2026, and 246 shares on 03/06/2026. The securities included restricted stock that vested on 05/01/2026 and were listed as compensation-related on the securities to be sold line.

Insights

Insider Transactions Analyst

Routine, small-scale insider sales under Rule 144; no material position change shown.

Robert F. Werner reported three discrete dispositions of Common Stock: 7,000 shares, 1,693 shares, and 246 shares on the dates listed in the filing. Each transaction is reported with sale dates and dollar amounts, indicating routine liquidity events.

These sales are small in absolute terms relative to typical company floats; the filing ties some securities to restricted stock vesting and labels them as compensation. Subsequent SEC filings would show any remaining holdings; timing and broader ownership context are not provided here.

Key Figures

Sale on 02/04/2026: 7,000 shares Sale on 02/23/2026: 1,693 shares Sale on 03/06/2026: 246 shares +2 more

5 metrics

Sale on 02/04/2026 7,000 shares Sale by Robert F. Werner recorded with $319,532.51 proceeds

Sale on 02/23/2026 1,693 shares Sale by Robert F. Werner recorded with $79,079.70 proceeds

Sale on 03/06/2026 246 shares Sale by Robert F. Werner recorded with $11,420.85 proceeds

Restricted stock vesting date 05/01/2026 Listed as vesting date for securities to be sold, source labeled Compensation

Broker-dealer reported Fidelity Brokerage Services LLC Broker listed with address and NASDAQ routing

Key Terms

Rule 144, Restricted Stock Vesting, Compensation

3 terms

Rule 144 regulatory

"Form type is 144 used for proposed dispositions under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Securities To Be Sold line shows 'Restricted Stock Vesting' dated 05/01/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"Securities To Be Sold entry lists 'Compensation' as the source"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	164	9372.40	61311704	05/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2026	Restricted Stock Vesting	Issuer			164	05/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert F. Werner 681 Gateway Blvd South San Francisco CA 94080	Common	02/04/2026	7000	319532.51
Robert F. Werner 681 Gateway Blvd South San Francisco CA 94080	Common	02/23/2026	1693	79079.70
Robert F. Werner 681 Gateway Blvd South San Francisco CA 94080	Common	03/06/2026	246	11420.85

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)